temozolomide has been researched along with Lymphocytosis in 2 studies
Lymphocytosis: Excess of normal lymphocytes in the blood or in any effusion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide is an alkylating agent approved for treatment of glioblastoma in association with radiotherapy." | 3.74 | [Alveolo-interstitial pneumonia due to Temozolamide]. ( Autret-Leca, E; Beau Salinas, F; Carré, P; de Luca, K; Diot, P; Guilleminault, L; Narciso, B, 2008) |
| " Overall, we have verified that TMZ in addition to being an alkylating and cytotoxic chemotherapy, also possess immune modulatory effect in MM patients treated with standard dosage of TMZ." | 2.49 | Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer. ( Iversen, TZ, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iversen, TZ | 1 |
| Guilleminault, L | 1 |
| Carré, P | 1 |
| de Luca, K | 1 |
| Beau Salinas, F | 1 |
| Autret-Leca, E | 1 |
| Narciso, B | 1 |
| Diot, P | 1 |
1 review available for temozolomide and Lymphocytosis
| Article | Year |
|---|---|
Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Carcinoma, Non-Small-Cell Lung; Dac | 2013 |
1 other study available for temozolomide and Lymphocytosis
| Article | Year |
|---|---|
[Alveolo-interstitial pneumonia due to Temozolamide].
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Bronchoalveolar Lavage; Dacarbazine; Female; Gli | 2008 |